San Marcos, CA, United States of America

Jim Leisten

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 17.0

ph-index = 2

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Jim Leisten: Innovator in Aminopurine Compounds

Introduction

Jim Leisten is a notable inventor based in San Marcos, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of aminopurine compounds. With a total of 5 patents to his name, Leisten continues to push the boundaries of innovation in his area of expertise.

Latest Patents

Among his latest patents is a groundbreaking work titled "Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith." This patent provides detailed information on aminopurine compounds that have unique structures and potential therapeutic applications. His research focuses on the development of these compounds, which could lead to advancements in medical treatments.

Career Highlights

Jim Leisten is currently employed at Signal Pharmaceuticals, Inc., where he applies his expertise in drug development and innovation. His work at the company has positioned him as a key player in the pharmaceutical industry, contributing to the advancement of new treatments and therapies.

Collaborations

Throughout his career, Leisten has collaborated with talented individuals such as Matthew David Alexander and Sogole Bahmanyar. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of innovative solutions.

Conclusion

Jim Leisten's contributions to the field of aminopurine compounds exemplify his dedication to innovation and research. His work continues to impact the pharmaceutical industry positively, paving the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…